Effects of polyamine depletion by α-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells

[1]  Xin Hu,et al.  Interaction between Polyamines and the Mitogen-Activated Protein Kinase Pathway in the Regulation of Cell Cycle Variables in Breast Cancer Cells. , 2005, Cancer research.

[2]  D. Welch,et al.  Metastasis of hormone-independent breast cancer to lung and bone is decreased by α-difluoromethylornithine treatment , 2005, Breast Cancer Research.

[3]  Xin Hu,et al.  Biological activity of the S-adenosylmethionine decarboxylase inhibitor SAM486A in human breast cancer cells in vitro and in vivo. , 2004, International journal of oncology.

[4]  E. Gerner,et al.  Polyamines and cancer: old molecules, new understanding , 2004, Nature Reviews Cancer.

[5]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[6]  D. Kramer,et al.  The role of mitogen-activated protein kinase activation in determining cellular outcomes in polyamine analogue-treated human melanoma cells. , 2003, Cancer research.

[7]  Paul J. Williams,et al.  Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma , 2000, Cancer.

[8]  L. Pfeffer,et al.  Inhibition of ornithine decarboxylase induces STAT3 tyrosine phosphorylation and DNA binding in IEC-6 cells. , 2000, American journal of physiology. Cell physiology.

[9]  J. Díaz,et al.  Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  T. Martin,et al.  A novel orthotopic model of breast cancer metastasis to bone , 1999, Clinical & Experimental Metastasis.

[11]  T. Patel,et al.  Polyamine depletion arrests cell cycle and induces inhibitors p21(Waf1/Cip1), p27(Kip1), and p53 in IEC-6 cells. , 1999, The American journal of physiology.

[12]  P. Gimotty,et al.  Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  J. Darnell,et al.  Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation , 1995, Cell.

[14]  F. Miller,et al.  Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. , 1992, Cancer research.

[15]  N. Seiler,et al.  Endogenous and exogenous polyamines in support of tumor growth. , 1990, Cancer research.

[16]  L. Persson,et al.  Increased formation of N1-acetylspermidine in human breast cancer. , 1989, Cancer letters.

[17]  A. Pegg,et al.  Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. , 1988, Cancer research.

[18]  Xin Hu,et al.  Effects of Polyamine Synthesis Inhibitors on Primary Tumor Features and Metastatic Capacity of Human Breast Cancer Cells , 2005, Clinical & Experimental Metastasis.

[19]  G. Matters,et al.  Inhibitors of Polyamine Biosynthesis Decrease the Expression of the Metalloproteases Meprin α and MMP-7 in Hormone-independent Human Breast Cancer Cells , 2005, Clinical & Experimental Metastasis.

[20]  A. Manni,et al.  Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor α-difluoromethylornithine (DFMO) in human breast cancer cells , 2004, Clinical & Experimental Metastasis.

[21]  D. Welch,et al.  Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells , 2004, Clinical & Experimental Metastasis.

[22]  D. Welch,et al.  Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice. , 2003, Clinical & experimental metastasis.

[23]  A. Manni.  Role of the Polyamine Pathway in the Natural History of Breast Cancer , 1999 .